TSP-1 (Thrombospondin-1) Deficiency Protects ApoE -/- Mice Against Leptin-Induced Atherosclerosis

• Published in: Arteriosclerosis, thrombosis, and vascular biology Vol. 41; no. 2; pp. e112 - e127
• Main Authors: Ganguly, Rituparna, Khanal, Saugat, Mathias, Amy, Gupta, Shreya, Lallo, Jason, Sahu, Soumyadip, Ohanyan, Vahagn, Patel, Aakaash, Storm, Kyle, Datta, Sujay, Raman, Priya
• Format: Journal Article
• Language: English
• Published: United States 01.02.2021
• Subjects: Animals; Aorta - metabolism; Aorta - pathology; Aortic Diseases - chemically induced; Aortic Diseases - metabolism; Aortic Diseases - pathology; Aortic Diseases - prevention & control; Atherosclerosis - chemically induced; Atherosclerosis - metabolism; Atherosclerosis - pathology; Atherosclerosis - prevention & control; Cell Differentiation; Cell Proliferation; Cells, Cultured; Collagen - metabolism; Diet, High-Fat; Disease Models, Animal; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Muscle, Smooth, Vascular - metabolism; Muscle, Smooth, Vascular - pathology; Myocytes, Smooth Muscle - metabolism; Myocytes, Smooth Muscle - pathology; Plaque, Atherosclerotic; Signal Transduction; Thrombospondin 1 - deficiency; Thrombospondin 1 - genetics; atherosclerosis; smooth muscle; thrombospondins; leptin; obesity
• ISSN: 1079-5642; 1524-4636
• DOI: 10.1161/ATVBAHA.120.314962

Hyperleptinemia, hallmark of obesity, is a putative pathophysiologic trigger for atherosclerosis. We previously reported a stimulatory effect of leptin on TSP-1 (thrombospondin-1) expression, a proatherogenic matricellular protein implicated in atherogenesis. However, a causal role of TSP-1 in leptin-driven atherosclerosis remains unknown. Approach and Results: Seventeen-weeks-old ApoE and TSP-1 /ApoE double knockout mice, on normocholesterolemic diet, were treated with or without murine recombinant leptin (5 µg/g bwt, IP) once daily for 3 weeks. Using aortic root morphometry and en face lesion assay, we found that TSP-1 deletion abrogated leptin-stimulated lipid-filled lesion burden, plaque area, and collagen accumulation in aortic roots of ApoE mice, shown via Oil red O, hematoxylin and eosin, and Masson trichrome staining, respectively. Immunofluorescence microscopy of aortic roots showed that TSP-1 deficiency blocked leptin-induced inflammatory and smooth muscle cell abundance as well as cellular proliferation in ApoE mice. Moreover, these effects were concomitant to changes in VLDL (very low-density lipoprotein)-triglyceride and HDL (high-density lipoprotein)-cholesterol levels. Immunoblotting further revealed reduced vimentin and pCREB (phospho-cyclic AMP response element-binding protein) accompanied with augmented smooth muscle-myosin heavy chain expression in aortic vessels of leptin-treated double knockout versus leptin-treated ApoE ; also confirmed in aortic smooth muscle cells from the mice genotypes, incubated ± leptin in vitro. Finally, TSP-1 deletion impeded plaque burden in leptin-treated ApoE on western diet, independent of plasma lipid alterations. The present study provides evidence for a protective effect of TSP-1 deletion on leptin-stimulated atherogenesis. Our findings suggest a regulatory role of TSP-1 on leptin-induced vascular smooth muscle cell phenotypic transition and inflammatory lesion invasion. Collectively, these results underscore TSP-1 as a potential target of leptin-induced vasculopathy.